Colonic Diseases, Functional: Clinical Trials

74 trials for Colonic Diseases, Functional, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

41 completed, 10 unknown, 6 recruiting, 6 terminated. 74 Phase 3, 21 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 374Completed 41, Unknown 10, Recruiting 6, Terminated 6, Active not recruiting 4, Withdrawn 4, Not yet recruiting 2, Enrolling by invitation 1
Phase 221Completed 9, Unknown 8, Recruiting 2, Active not recruiting 1, Terminated 1

Follow Colonic Diseases, Functional: new trials by email Literature Review of Colonic Diseases, Functional trials Research Report on Colonic Diseases, Functional

Trials (filtered) newest first · largest first

All 74 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rifaximin Treatment in Bloating Predominant Functional Bowel Disorders
Rifaximin (drug), Placebo - Bloating, Rifaximin
Phase 3Not yet recruitingMahidol University782026-12-012026-10-27
Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome
Saccharomyces Boulardii 250 MG, Placebo 250 mg - IBS (Irritable Bowel Syndrome), IBS-D (Diarrhea-predominant)
Phase 3RecruitingBiocodex4062025-10-222025-11-18
Study of Fecal Microbiota Transplantation (FMT) in Severe IBS Patients
Administration of fecal microbiota transplantation ( FMT capsules), Administration of the sham (PLACEBO) - Irritable Bowel Syndrome
Phase 3Not yet recruitingAssistance Publique - Hôpitaux de Paris1502025-07-012025-06-27
Effects of Standardized Boswellia Carterii Extract on Irritable Bowel Syndrome Patients
Boswellia carterii Extract, Educationntal program for IBS patie - Irritable Bowel Syndrome
Phase 2 / Phase 3CompletedMansoura University602025-01-012026-05-08
Ebastine Versus Mebeverine in IBS Patients
Ebastine, Duspatalin - IBS - Irritable Bowel Syndrome, IBS
Phase 3Active not recruitingGuy Boeckxstaens2002023-03-302026-09-11
Home Transcutaneous Electrical Acustimulation (TEA)
TEA, Lexapro - Irritable Bowel Syndrome With Constipation
Phase 2 / Phase 3RecruitingUniversity of Michigan1602022-11-022026-09-17
Peppermint Oil for the Treatment of Irritable Bowel Syndrome or Functional Abdominal Pain in Children: the MINT Study
Small intestinal release peppermint oil, Peppermint sweets, Placebo - Irritable Bowel Syndrome, Functional Abdominal Pain Syndrome
Phase 3CompletedSt. Antonius Hospital2282022-05-122025-05-30
Neurocognitive Effects of FMT in MDD Patients With and Without IBS
Fecal Microbiota Transplantation - Major Depressive Disorder, Irritable Bowel Syndrome
Phase 2 / Phase 3Active not recruitingValerie Taylor1332022-04-062026-03-19
Recurrent Abdominal Pain and Exocrine Pancreatic Insufficiency
synthetic human secretin - Abdominal Pain, Irritable Bowel Syndrome
Phase 3TerminatedOrlando Health, Inc.272022-01-282024-04-03
Efficacy of a Low FODMAP Diet in the Absence of Lactose Malabsorption in Moderate to Severe ROME IV IBS.
FODMAP diet - Irritable Bowel Syndrome
Phase 3RecruitingUniversitair Ziekenhuis Brussel602021-11-022025-12-18
Predictive Value of Hydrogen/Methane Lactose Breath Testing on the Therapeutic Effect of Lactose-free Diet in Moderate to Severe ROME IV IBS.
low fat diet - Irritable Bowel Syndrome, Lactose Intolerant
Phase 3RecruitingUniversitair Ziekenhuis Brussel902021-10-222025-12-18
A Study Evaluating Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D)
25mg Eluxadoline, 100mg Eluxadoline - Irritable Bowel Syndrome
Phase 3Enrolling by invitationAbbVie1242021-08-132025-07-17
Donor Versus Autologous Fecal Microbiota Transplantation for Irritable Bowel Syndrome
Fecal microbiota transplantation (FMT) - Irritable Bowel Syndrome
Phase 3Active not recruitingUniversity Hospital of North Norway4502021-05-052024-02-26
The Effects of Prucalopride in Patients With Constipation Predominant Irritable Bowel Syndrome
Prucalopride 2mg - Irritable Bowel Syndrome
Phase 2 / Phase 3UnknownBangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh1602021-03-102021-10-22
Prebiotics for Spinal Cord Injury Patients With Bowel and Bladder Dysfunction
Human Milk Oligosaccharides (HMO), Placebo - Spinal Cord Injuries, Neurogenic Bowel
Phase 3CompletedLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's302021-01-272023-12-13
Neostigmine and Glycopyrrolate by Iontophoresis
Combination of Neostigmine and Glycopyrrolate, I-Box by Dynatronics - Spinal Cord Injuries, Constipation
Phase 3Active not recruitingJames J. Peters Veterans Affairs Medical Center62020-11-062024-04-08
Frequency of Sleep Abnormalities in Patients With Irritable Bowel Syndrome and Effect of Pharmacological Intervention
Melatonin 3 mg, Placebo - Irritable Bowel Syndrome
Phase 3UnknownSanjay Gandhi Postgraduate Institute of Medical Sciences1942020-02-012020-03-16
Antihistamines in the Treatment of Irritable Bowel Syndrome With Diarrhea
Antihistamine, Placebo - Irritable Bowel Syndrome, Dermatographism
Phase 3WithdrawnUniversity of Cincinnati2020-02-012026-09-04
Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome
pentoxyifylline, Mebeverine, ethosuximide - IBS - Irritable Bowel Syndrome
Phase 3RecruitingTanta University602019-11-012020-01-03
Efficacy and Safety of Chinese Medicine JCM-16021 for Diarrhea-predominant Irritable Bowel Syndrome
JCM-16021, Placebo - Irritable Bowel Syndrome
Phase 2 / Phase 3UnknownZhaoXiang Bian3922018-11-082020-08-19

Showing 20 of 74. Sign in to see all of them.

Narrower conditions

Irritable Bowel Syndrome (71)  ·  Constipation (9)  ·  Diarrhea (9)  ·  Abdominal Pain (8)  ·  Intestinal Diseases (4)  ·  Gastrointestinal Diseases (3)  ·  Colonic Pseudo-Obstruction (2)  ·  Fibromyalgia (2)  ·  Neurogenic Bowel (2)  ·  Spinal Cord Injuries (2)  ·  Anxiety Disorders (1)  ·  Borderline Personality Disorder (1)  ·  Burning Mouth Syndrome (1)  ·  Chronic Pain (1)

Broader conditions

Colonic Diseases (73)  ·  Digestive System Diseases (73)  ·  Gastrointestinal Diseases (71)  ·  Intestinal Diseases (70)  ·  Pathological Conditions, Signs and Symptoms (25)  ·  Signs and Symptoms (24)  ·  Signs and Symptoms, Digestive (21)  ·  Neurologic Manifestations (10)  ·  Pain (10)  ·  Nervous System Diseases (4)  ·  Central Nervous System Diseases (3)  ·  Mental Disorders (3)  ·  Behavior (2)  ·  Behavioral Symptoms (2)

Interventions

Fecal Microbiota Transplantation (6)  ·  Sugars (6)  ·  Mesalamine (3)  ·  Rifaximin (3)  ·  eluxadoline (3)  ·  ibodutant (3)  ·  Acetylglucosamine (2)  ·  Probiotics (2)  ·  alosetron (2)  ·  mebeverine (2)  ·  6-methylbenzo(b)thiophene-2-carboxylic acid (1-(2-phenyl-((1-(tetrahydropyran-4-ylmethyl)piperidin-4-ylmethyl)carbamoyl)ethylcarbamoyl)cyclophenyl)amide (1)  ·  Anti-Bacterial Agents (1)  ·  Antidepressive Agents (1)  ·  Cetirizine (1)  ·  Control Groups (1)

Sponsors

Menarini Group (3)  ·  Astellas Pharma Inc (2)  ·  Furiex Pharmaceuticals, Inc (2)  ·  GlaxoSmithKline (2)  ·  SOFAR S.p.A. (2)  ·  Third Military Medical University (2)  ·  Universitair Ziekenhuis Brussel (2)  ·  University Hospital of North Norway (2)  ·  University of Utah (2)  ·  AbbVie (1)  ·  Aleris-Hamlet Hospitaler København (1)  ·  Alizyme (1)  ·  American University of Beirut Medical Center (1)  ·  Ashok Tuteja (1)  ·  Assistance Publique - Hôpitaux de Paris (1)

Countries

United States (23)  ·  United Kingdom (10)  ·  Canada (8)  ·  Germany (6)  ·  Italy (6)  ·  China (5)  ·  France (5)  ·  Belgium (4)  ·  Czechia (4)  ·  Norway (4)  ·  Poland (4)  ·  South Korea (4)  ·  Australia (3)  ·  Iran (3)  ·  Netherlands (3)

Top investigators

Junkang Liu, Doctor (2)  ·  Lin Chang, Professor (2)  ·  A Masclee, Prof., PhD., MD. (1)  ·  Ala' I. Sharara, MD (1)  ·  Angela Bulawski (1)  ·  Anthony Lembo (1)  ·  Arine Vlieger, MD, PhD (1)  ·  Ashok Tuteja (1)  ·  Ashok Tuteja, MD, MPH (1)  ·  Barbara Giovanni, Doctor (1)  ·  Barbara Grube, MD (1)

Results publications

PMID 26789872, PMID 28167156, PMID 11239312, PMID 11491192, PMID 11914441, PMID 17013448, PMID 18972769, PMID 20594245, PMID 22347818, PMID 23116208, PMID 23554827, PMID 24075889, PMID 24815298, PMID 25533646, PMID 25987795, PMID 28252569, PMID 29980607, PMID 30136447, PMID 30277094, PMID 30525951, PMID 31470006, PMID 31499231, PMID 31945816, PMID 32620184, PMID 34468079, PMID 34726293, PMID 34774080, PMID 35221706, PMID 36375174, PMID 36866724, PMID 40639240, PMID 41610933, PMID 42320473, PMID 42785338, PMID 6880820, PMID 9146781

NIH funding

2015 (1), 2019 (1), 5UH3NS115108-04 (1), R01DK049334 (1), R01NR004142 (1)